ADVERTISEMENT
Conference Coverage
Walter Maksymowych, MD, on Upadacitinib in Axial Spondyloarthritis
12/13/2022
Dr Maksymowych discusses the results of a randomized clinical trial of upadacitinib vs placebo among patients with radiographic and nonradiographic axial spondyloarthritis.
Walter Maksymowych, MD, is a professor of medicine at the University of Alberta in Edmonton, Alberta, Canada, and cofounder and principal investigator the Spondyloarthritis Research Consortium of Canada (SPARCC).
Stay in the Know
Rheumatology & Arthritis Newsletter
